4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide

C90H105Br3Cl6N26O12 — CID 158326895

About 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide

4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide (PubChem CID 158326895) has the molecular formula C90H105Br3Cl6N26O12 and a molecular weight of 2195.43 g/mol. Its IUPAC name is 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide.

Molecular Properties

• Compound Name: 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide
• PubChem CID: 158326895
• Molecular Formula: C90H105Br3Cl6N26O12
• Molecular Weight: 2195.43 g/mol
• Exact Mass: 2188.41
• IUPAC Name: 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide
• SMILES: CC(=O)OC1CCC(C(=O)NCc2nccnc2Cl)CC1.CC(=O)OC1CCC(c2nc(Br)c3c(Cl)nccn23)CC1.CC(=O)OC1CCC(c2nc(Br)c3c(N)nccn23)CC1.CC(=O)OC1CCC(c2ncc3c(Cl)nccn23)CC1.N#Cc1nccnc1Cl.NCc1nccnc1Cl.Nc1nccn2c(C3CCC(O)CC3)nc(Br)c12.O=C(NCc1nccnc1Cl)C1CCC(O)CC1
• InChI: InChI=1S/C14H15BrClN3O2.C14H17BrN4O2.C14H18ClN3O3.C14H16ClN3O2.C12H15BrN4O.C12H16ClN3O2.C5H6ClN3.C5H2ClN3/c2*1-8(20)21-10-4-2-9(3-5-10)14-18-12(15)11-13(16)17-6-7-19(11)14;1-9(19)21-11-4-2-10(3-5-11)14(20)18-8-12-13(15)17-7-6-16-12;1-9(19)20-11-4-2-10(3-5-11)14-17-8-12-13(15)16-6-7-18(12)14;13-10-9-11(14)15-5-6-17(9)12(16-10)7-1-3-8(18)4-2-7;13-11-10(14-5-6-15-11)7-16-12(18)8-1-3-9(17)4-2-8;2*6-5-4(3-7)8-1-2-9-5/h6-7,9-10H,2-5H2,1H3;6-7,9-10H,2-5H2,1H3,(H2,16,17);6-7,10-11H,2-5,8H2,1H3,(H,18,20);6-8,10-11H,2-5H2,1H3;5-8,18H,1-4H2,(H2,14,15);5-6,8-9,17H,1-4,7H2,(H,16,18);1-2H,3,7H2;1-2H
• InChIKey: GPNFAGFTTLRRSP-UHFFFAOYSA-N
• XLogP: 16.22
• TPSA: 529.59 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 36
• Rotatable Bonds: 15
• Heavy Atoms: 137
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2195.43
LogP ≤ 5	16.22
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	36

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide?

The IUPAC name of 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide (CID 158326895) is 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide.

What is the SMILES notation for 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide?

The canonical SMILES for 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide is CC(=O)OC1CCC(C(=O)NCc2nccnc2Cl)CC1.CC(=O)OC1CCC(c2nc(Br)c3c(Cl)nccn23)CC1.CC(=O)OC1CCC(c2nc(Br)c3c(N)nccn23)CC1.CC(=O)OC1CCC(c2ncc3c(Cl)nccn23)CC1.N#Cc1nccnc1Cl.NCc1nccnc1Cl.Nc1nccn2c(C3CCC(O)CC3)nc(Br)c12.O=C(NCc1nccnc1Cl)C1CCC(O)CC1.

What is the InChIKey of 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide?

The InChIKey is GPNFAGFTTLRRSP-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H15BrClN3O2.C14H17BrN4O2.C14H18ClN3O3.C14H16ClN3O2.C12H15BrN4O.C12H16ClN3O2.C5H6ClN3.C5H2ClN3/c2*1-8(20)21-10-4-2-9(3-5-10)14-18-12(15)11-13(16)17-6-7-19(11)14;1-9(19)21-11-4-2-10(3-5-11)14(20)18-8-12-13(15)17-7-6-16-12;1-9(19)20-11-4-2-10(3-5-11)14-17-8-12-13(15)16-6-7-18(12)14;13-10-9-11(14)15-5-6-17(9)12(16-10)7-1-3-8(18)4-2-7;13-11-10(14-5-6-15-11)7-16-12(18)8-1-3-9(17)4-2-8;2*6-5-4(3-7)8-1-2-9-5/h6-7,9-10H,2-5H2,1H3;6-7,9-10H,2-5H2,1H3,(H2,16,17);6-7,10-11H,2-5,8H2,1H3,(H,18,20);6-8,10-11H,2-5H2,1H3;5-8,18H,1-4H2,(H2,14,15);5-6,8-9,17H,1-4,7H2,(H,16,18);1-2H,3,7H2;1-2H.

What are the key properties of 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide?

4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide has a molecular weight of 2195.43 g/mol, XLogP of 16.22, 15 rotatable bonds, 7 hydrogen bond donors, and 36 hydrogen bond acceptors.

Where does this data come from?

All data for 4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexan-1-ol;[4-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;[4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl] acetate;3-chloropyrazine-2-carbonitrile;(3-chloropyrazin-2-yl)methanamine;[4-[(3-chloropyrazin-2-yl)methylcarbamoyl]cyclohexyl] acetate;N-[(3-chloropyrazin-2-yl)methyl]-4-hydroxycyclohexane-1-carboxamide is sourced from PubChem (CID 158326895), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).